Yale University
New Haven, Connecticut, 06519, United States
NCT Number: NCT04341363
The intent of this study is to evaluate the efficacy of microneedling through use of a professional tattoo machine in hair regrowth in patients with androgenic alopecia (AGA) over up to 6 treatments (6 months).
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
New Haven, Connecticut, 06519, United States
Proposed is an open label trial of tattoo machine microneedling in ten patients with androgenic alopecia. Ten healthy male patients older than 18 years will undergo 6 microneedling sessions. Over the course of six months, subjects will undergo up to six treatment sessions (one session every 30 day). Patients will be evaluated at 8 visits over 8 months with the first visit for screening purposes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A SOL Nova Device (brand) tattoo machine will be used to stimulate hair regrowth.
Time frame: 6 months
Total number of hairs in an area of 1 cm^2
Time frame: 6 months
The Severity of Alopecia Tool measures percentage of scalp hair loss
Time frame: 6 months
The diameter of the hair shaft as measured by trichoscopy
Time frame: 6 months
Number of follicular units with one or more hair follicles over an area of 1cm^2
Time frame: 6 months
Number of vellus hairs over an area of 1 cm^2
Time frame: 6 months
Terminal hairs over an area of 1 cm^2
Yale University
Other
Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07348315
Alopecia, Androgenic Alopecia
Chengdu, Sichuan, China
View Trial DetailsNCT06556056
Alopecia, Androgenic Alopecia
Ahmedabad, Gujarat, India
View Trial DetailsNCT06576492
Alopecia, Androgenic Alopecia
Madrid, Chamartin, Spain
View Trial DetailsNCT06112782
Alopecia, Androgenic Alopecia
Los Angeles, California, United States
View Trial Details